Last reviewed · How we verify
L19TNF and CCNU — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
L19TNF and CCNU (L19TNF and CCNU) — Philogen S.p.A..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| L19TNF and CCNU TARGET | L19TNF and CCNU | Philogen S.p.A. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- L19TNF and CCNU CI watch — RSS
- L19TNF and CCNU CI watch — Atom
- L19TNF and CCNU CI watch — JSON
- L19TNF and CCNU alone — RSS
Cite this brief
Drug Landscape (2026). L19TNF and CCNU — Competitive Intelligence Brief. https://druglandscape.com/ci/l19tnf-and-ccnu. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab